Abdulrahman Nasiri: Bone Marrow Biopsy Safety on Anticoagulation
Abdulrahman Nasiri, Hematologist, Assistant Professor at Imam Muhammad ibn Saud Islamic University, posted on LinkedIn:
”Honored to be participating in the MENA Hematology Congress 2025 held in Al-Madinah, where I presented our paper titled:
Safety of Bone Marrow Biopsy in Patients Receiving Anticoagulation Therapy
A Systematic Review and Meta-Analysis
This work reviewed more than 65,000 bone marrow biopsy procedures, including over 1,000 anticoagulated patients. The analysis showed that bone marrow biopsy maintains an excellent safety profile, even in patients on anticoagulation, and highlighted the patient-specific factors that truly influence bleeding risk.
Grateful for the opportunity to share this research among distinguished hematologists and researchers across the region.
The congress is still ongoing, and I look forward to the remaining sessions and discussions.
My appreciation to the organizers for a well-executed scientific meeting and to colleagues who enriched the exchange with their insights.”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch